DFO
VCYT icon

Duquesne Family Office’s Veracyte VCYT Stock Holding History

Duquesne Family Office’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-259,944
Closed -$5.63M – 96
2024
Q2 		$5.63M Hold
259,944
– – 0.19% 45
2024
Q1 		$5.76M Buy
+259,944
New +$6.34M 0.13% 57

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Duquesne Family Office's VCYT Position: Q3 2024 in Review

Duquesne Family Office sold out of Veracyte (VCYT) in Q3 2024, closing a stake of 259,944 shares — an estimated $5.63M sold.

Duquesne Family Office first reported a position in VCYT in Q1 2024 and held it in 2 quarters. The position peaked at $5.76M in Q1 2024. 293 funds tracked by Wall St. Rank hold VCYT as of Q3 2024.

  • Duquesne Family Office reported no remaining Veracyte position as of Q3 2024 after selling out during the quarter.
  • Duquesne Family Office sold 259,944 Veracyte shares in Q3 2024, an estimated $5.63M.
  • Duquesne Family Office first reported a position in Veracyte in Q1 2024 and held it in 2 quarters.
  • Duquesne Family Office's Veracyte position peaked at $5.76M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Veracyte as of Q3 2024.

Based on Duquesne Family Office's 13F filing for Q3 2024, filed 14 Nov 2024.